X4 Pharmaceuticals reported revenue of $8.81M and net income of -$16.16M for the quarter ended Jun 2026, up 346.3% year over year. This income statement covers 38 quarters of results from Mar 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||||||||||||||||
| Revenue | 0.56M | 0.56M | 1.43M | 28.81M | 1.97M | 1.76M | 2.57M | 2.71M | 8.81M | |||||||||||||||||||||||||||||
| Cost of RevenueCost of Rev | 0.27M | 0.23M | 0.30M | 4.72M | 0.33M | 0.35M | 0.36M | 0.60M | 1.62M | |||||||||||||||||||||||||||||
| Gross Profit | 0.29M | 0.33M | 1.13M | 24.09M | 1.65M | 1.41M | 2.20M | 2.11M | 7.19M | |||||||||||||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 13.19M | 12.16M | 14.11M | 13.82M | 14.11M | 19.01M | 22.06M | 15.60M | 19.08M | 15.27M | 19.85M | 20.91M | 19.17M | 21.70M | 18.51M | 18.35M | 17.34M | 18.52M | 15.45M | 15.08M | ||||||||||||||||||
| Selling, General & AdministrativeSG&A | 5.93M | 7.13M | 7.66M | 6.75M | 6.04M | 6.56M | 7.24M | 10.20M | 8.13M | 9.93M | 17.43M | 13.28M | 15.66M | 15.14M | 15.02M | 9.53M | 11.59M | 7.38M | 6.97M | 8.50M | ||||||||||||||||||
| Other Operating ExpensesOther Opex | 0.51M | -0.51M | 105.00M | |||||||||||||||||||||||||||||||||||
| Operating ExpensesOpex | 19.12M | 29.05M | 21.27M | 20.57M | 20.15M | 25.58M | 29.30M | 25.80M | 27.21M | 25.20M | 37.29M | 34.19M | 34.83M | 36.85M | 33.53M | 27.88M | 28.92M | 25.90M | 22.42M | 23.58M | ||||||||||||||||||
| Operating IncomeOp. Inc | -19.12M | -29.05M | -21.27M | -20.57M | -20.15M | -25.58M | -29.30M | -25.80M | -27.21M | -25.20M | -37.29M | 71.10M | -34.50M | -35.72M | -9.44M | -26.23M | -27.51M | -23.70M | -20.31M | -16.39M | ||||||||||||||||||
| EBIT | -19.12M | -29.05M | -21.27M | -20.57M | -20.15M | -25.58M | -29.30M | -25.80M | -27.21M | -25.20M | -37.29M | 71.10M | -34.50M | -35.72M | -9.44M | -26.23M | -27.51M | -23.70M | -20.31M | -16.39M | ||||||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.92M | 0.93M | 0.91M | 0.92M | 1.02M | 1.14M | 1.11M | 1.15M | 1.63M | 1.89M | 1.87M | 2.18M | 2.41M | 2.30M | 2.20M | 2.23M | 2.26M | 2.19M | 2.13M | 2.16M | ||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M | 0.20M | 0.83M | 0.91M | 1.39M | 1.45M | 1.07M | 1.56M | 1.87M | 1.27M | 1.02M | 0.67M | 0.90M | 1.99M | 2.10M | 1.98M | ||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.07M | 0.10M | 0.18M | -0.06M | -0.44M | -3.76M | 0.12M | 0.20M | 25.16M | 6.33M | -13.76M | 20.21M | -1.86M | 0.70M | 10.83M | 2.64M | -0.68M | 0.08M | 0.53M | |||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | -1.05M | -1.15M | -0.67M | -0.64M | -1.45M | -3.51M | 5.29M | -29.89M | 24.93M | 6.10M | -14.46M | 19.75M | -2.18M | -3.85M | 9.76M | 0.53M | -2.34M | -0.23M | 0.07M | 0.24M | ||||||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||||||||
| EBT | -20.17M | -30.20M | -21.94M | -21.21M | -21.60M | -29.09M | -24.02M | -55.70M | -2.28M | -19.10M | -51.75M | 90.85M | -36.68M | -39.56M | 0.32M | -25.70M | -29.84M | -23.93M | -20.24M | -16.16M | ||||||||||||||||||
| Tax ProvisionsTaxes | 0.00M | 0.00M | 0.02M | 0.00M | -0.01M | 0.01M | 0.00M | 0.01M | 0.03M | 0.03M | 0.02M | 0.02M | 0.01M | 0.26M | 0.03M | 0.04M | -0.03M | 0.00M | ||||||||||||||||||||
| Profit After TaxPAT | -20.18M | -30.21M | -21.96M | -21.21M | -21.59M | -29.10M | -24.02M | -55.71M | -2.31M | -19.13M | -51.77M | 90.83M | -36.70M | -39.82M | 0.28M | -25.74M | -29.82M | -23.90M | -20.24M | -16.16M | ||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -20.18M | -30.21M | -21.96M | -21.21M | -21.59M | -29.10M | -24.02M | -55.71M | -2.31M | -19.13M | -51.77M | 90.83M | -36.70M | -39.82M | 0.28M | -25.74M | -29.82M | -23.93M | -20.24M | -16.16M | ||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -20.18M | -30.21M | -21.96M | -21.21M | -21.59M | -29.10M | -24.02M | -55.71M | -2.31M | -19.13M | -51.77M | 90.83M | -36.70M | -39.82M | 0.28M | -25.74M | -29.82M | -23.93M | -20.24M | -16.16M | ||||||||||||||||||
| Income towards Parent CompanyParent Net Inc | -20.18M | -30.21M | -21.96M | -21.21M | -21.59M | -29.10M | -24.02M | -55.71M | -2.31M | -19.13M | -51.77M | 90.83M | -36.70M | -39.82M | 0.28M | -25.74M | -29.82M | -23.93M | -20.24M | -16.16M | ||||||||||||||||||
| Preferred Dividend PaymentsPref Dividends | 2.26M | 0.29M | 0.04M | 0.01M | -0.04M | 0.01M | 0.01M | 0.01M | -0.02M | -0.01M | 0.01M | 0.00M | ||||||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -20.18M | -35.91M | -24.22M | -21.21M | -21.87M | -29.10M | -24.02M | -55.71M | -2.31M | -19.13M | -51.80M | 90.83M | -36.65M | -39.83M | 0.28M | -25.75M | -29.80M | -23.92M | -20.25M | -16.16M | ||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||||
| EPS (Basic) | -0.76 | -1.39 | -0.72 | -0.60 | -0.26 | -0.46 | -0.16 | -0.33 | -0.01 | -0.11 | -0.26 | 0.45 | -5.47 | -5.94 | 0.04 | -3.47 | -0.69 | -0.57 | -0.16 | -0.13 | ||||||||||||||||||
| EPS (Diluted) | -0.76 | -1.39 | -0.72 | -0.60 | -0.26 | -0.46 | -0.16 | -0.33 | -0.01 | -0.11 | -0.26 | 0.45 | -0.18 | -0.20 | 0.04 | -3.47 | -0.69 | -0.57 | -0.16 | -0.13 | ||||||||||||||||||
| Shares Outstanding | 26.61M | 25.75M | 33.74M | 35.44M | 83.21M | 63.53M | 145.97M | 168.74M | 196.99M | 177.81M | 199.99M | 200.44M | 6.70M | 6.70M | 6.84M | 7.41M | 43.27M | 42.29M | 126.29M | 126.34M | ||||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 26.61M | 25.75M | 33.74M | 35.44M | 83.21M | 63.53M | 145.97M | 168.74M | 196.99M | 177.81M | 199.99M | 200.80M | 200.87M | 201.06M | 6.87M | 7.41M | 43.27M | 42.29M | 126.29M | 126.34M | ||||||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 24.71M | 28.13M | 30.81M | 30.99M | 68.73M | 63.53M | 122.21M | 164.42M | 164.71M | 177.81M | 199.99M | 200.44M | 5.62M | 5.70M | 5.79M | 7.96M | 43.27M | 42.29M | 126.29M | 126.34M | ||||||||||||||||||
| EBITDA | -19.12M | -29.05M | -21.27M | -20.57M | -20.15M | -25.58M | -29.30M | -25.80M | -27.21M | -25.20M | -37.29M | 71.10M | -34.50M | -35.72M | -9.44M | -26.23M | -27.51M | -23.70M | -20.31M | -16.39M | ||||||||||||||||||
| Interest ExpensesInt Expense | 0.92M | 0.93M | 0.91M | 0.92M | 1.02M | 1.14M | 1.11M | 1.15M | 1.63M | 1.89M | 1.87M | 2.18M | 2.41M | 2.30M | 2.20M | 2.23M | 2.26M | 2.19M | 2.13M | 2.16M | ||||||||||||||||||
| Tax Rate | -0.01% | -0.01% | -0.10% | -0.02% | 0.06% | -0.05% | -0.02% | -0.03% | -1.14% | -0.17% | -0.04% | 0.02% | -0.04% | -0.65% | 10.76% | -0.14% | 0.10% | -0.01% |